Amedisys (AMED) Tops Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amedisys Reports First Quarter 2021 Financial Results Updates 2021 Guidance
April 28, 2021 4:05 PM EDTBATON ROUGE, La., April 28, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2021.
Three-Month Periods Ended March 31, 2021 and 2020
Net service revenue increased $45.4Â million to $537.1Â million compared to $491.7Â million in 2020.Net income attributable to Amedisys, Inc. of $49.9Â million compared to $31.8Â million in 2020.Net income attributable to Amedisys, Inc. per diluted share of $1.50 compared to $0.96 in 2020.Adjusted Quarterly Results*
Adjusted EBITDA of $78.6Â million compared to $53.3Â million in 2020.Adjusted net income attributable to Amedisys, Inc. of $51.1Â million compared to... More


